Literature DB >> 10207531

Synovial fluid sampling from the temporomandibular joint: sample quality criteria and levels of interleukin-1 beta and serotonin.

P Alstergren1, S Kopp, E Theodorsson.   

Abstract

The aims of this study were to compare two sets of quality criteria (SQC A and B) with respect to synovial fluid (SF) sampling and to present temporomandibular joint (TMJ) SF levels of IL-1 beta and 5-HT. The study comprised 310 TMJ SF samples from 12 healthy individuals (HI) and 59 patients with TMJ inflammatory disorders. Ten HI and 37 patients were selected for investigation of TMJ SF levels and samples were obtained by a push-and-pull method with quantification by vitamin B12. The SQC comprised aspirate weight (AW), dilution factor (DF), blood contamination and hemolysis. IL-1 beta and 5-HT levels did not differ between the samples that satisfied SQC A or B. The proportion of samples that satisfied SQC A was higher than for SQC B. Patients with polyarthritides had significantly higher TMJ SF concentrations of 5-HT and IL-1 beta than HL. In conclusion, there is a recovery of TMJ SF of 0.1-0.2 g with the method used and the criteria set with the highest success rate do not differ from the other one with respect to SF levels of IL-1 beta and 5-HT. This set of sample quality criteria comprised no hemolysis, no or only minor blood contamination, AW > 0.5 g and DF < 0.98. The higher SF levels in the diseased TMJ (polyarthritides) compared to the healthy joint with respect to 5-HT and IL-1 beta is of clinical diagnostic relevance and the presence of 5-HT or IL-1 beta in TMJ SF seems to indicate a pathological joint condition probably of an inflammatory nature.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10207531     DOI: 10.1080/000163599429057

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  10 in total

Review 1.  Expanding the taxonomy of the diagnostic criteria for temporomandibular disorders.

Authors:  C C Peck; J-P Goulet; F Lobbezoo; E L Schiffman; P Alstergren; G C Anderson; R de Leeuw; R Jensen; A Michelotti; R Ohrbach; A Petersson; T List
Journal:  J Oral Rehabil       Date:  2014-01       Impact factor: 3.837

2.  3D osteoarthritic changes in TMJ condylar morphology correlates with specific systemic and local biomarkers of disease.

Authors:  L H S Cevidanes; D Walker; J Schilling; J Sugai; W Giannobile; B Paniagua; E Benavides; H Zhu; J S Marron; B T Jung; D Baranowski; J Rhodes; A Nackley; P F Lim; J B Ludlow; T Nguyen; J R Goncalves; L Wolford; S Kapila; M Styner
Journal:  Osteoarthritis Cartilage       Date:  2014-10       Impact factor: 6.576

3.  Cyclic tensile strain suppresses catabolic effects of interleukin-1beta in fibrochondrocytes from the temporomandibular joint.

Authors:  S Agarwal; P Long; R Gassner; N P Piesco; M J Buckley
Journal:  Arthritis Rheum       Date:  2001-03

4.  IL-1beta suppresses the formation of osteoclasts by increasing OPG production via an autocrine mechanism involving celecoxib-related prostaglandins in chondrocytes.

Authors:  Yusuke Watanabe; Aki Namba; Yukiko Aida; Kazuhiro Honda; Hideki Tanaka; Naoto Suzuki; Hideo Matsumura; Masao Maeno
Journal:  Mediators Inflamm       Date:  2010-02-24       Impact factor: 4.711

5.  Tumor necrosis factor-alpha in temporomandibular joint synovial fluid predicts treatment effects on pain by intra-articular glucocorticoid treatment.

Authors:  Lars Fredriksson; Per Alstergren; Sigvard Kopp
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

6.  Serotonergic mechanisms influence the response to glucocorticoid treatment in TMJ arthritis.

Authors:  Lars Fredriksson; Per Alstergren; Sigvard Kopp
Journal:  Mediators Inflamm       Date:  2005-08-31       Impact factor: 4.711

7.  Elastin‑derived peptides are involved in the processes of human temporomandibular disorder by inducing inflammatory responses in synovial cells.

Authors:  Kazuhiko Kobayashi; Rei Jokaji; Mayuko Miyazawa-Hira; Shigeyuki Takatsuka; Akira Tanaka; Kazuhiro Ooi; Hiroyuki Nakamura; Shuichi Kawashiri
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

8.  Controversial Aspects of Diagnostics and Therapy of Arthritis of the Temporomandibular Joint in Rheumatoid and Juvenile Idiopathic Arthritis-An Analysis of Evidence- and Consensus-Based Recommendations Based on an Interdisciplinary Guideline Project.

Authors:  Christopher Schmidt; Rudolf Reich; Bernd Koos; Taila Ertel; Marcus Oliver Ahlers; Martin Arbogast; Ima Feurer; Mario Habermann-Krebs; Tim Hilgenfeld; Christian Hirsch; Boris Hügle; Thekla von Kalle; Johannes Kleinheinz; Andreas Kolk; Peter Ottl; Christoph Pautke; Merle Riechmann; Andreas Schön; Linda Skroch; Marcus Teschke; Wolfgang Wuest; Andreas Neff
Journal:  J Clin Med       Date:  2022-03-22       Impact factor: 4.241

9.  Cytokines in temporomandibular joint synovial fluid and tissue in relation to inflammation.

Authors:  Mattias Ulmner; Rachael Sugars; Aron Naimi-Akbar; Per Alstergren; Bodil Lund
Journal:  J Oral Rehabil       Date:  2022-04-09       Impact factor: 3.558

10.  Efficacy and safety of intraarticular corticosteroid injections in adolescents with juvenile idiopathic arthritis in the temporomandibular joint: a Norwegian 2-year prospective multicenter pilot study.

Authors:  Paula Frid; Thomas A Augdal; Tore A Larheim; Josefine Halbig; Veronika Rypdal; Nils Thomas Songstad; Annika Rosén; Karin B Tylleskär; Johanna Rykke Berstad; Berit Flatø; Peter Stoustrup; Karen Rosendahl; Eva Kirkhus; Ellen Nordal
Journal:  Pediatr Rheumatol Online J       Date:  2020-10-01       Impact factor: 3.054

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.